Architect Anwar Hakim turned to UChicago Medicine for a second opinion on treatment for advanced melanoma. Oncologist and melanoma expert Jason Luke, MD, suggested a Phase 1 clinical trial of a combination immunotherapy based on UChicago Medicine research. The treatment worked quickly and side effects were minimal, allowing Hakim to maintain a full work and travel schedule while receiving the therapy. "Six years ago, we didn’t have much to offer patients with advanced melanoma," Luke said. "Now we are seeing unbelievable responses to immunotherapy."
An action-packed blog post by a patient with virulent, relentless asthma who was rescued by her UChicago physicians using a treatment with a scary name, but a comforting outcome. Her story also involves a tornado.